Ignite Creation Date:
2024-05-06 @ 10:56 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03381417
Status:
COMPLETED
Last Update Posted:
2018-01-02
First Post:
2017-12-11
Brief Title:
Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients
Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization Data
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Class:
INDUSTRY
Study ID:
NNG05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None